RecruitingNot ApplicableNCT05227547

Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease


Sponsor

Centre Hospitalier Intercommunal Creteil

Enrollment

186 participants

Start Date

Oct 5, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

To evaluate the regenerative capacities of mesenchymal cells composing the microenvironment of alveolar type 2 cells in a population of patients, undergoing thoracic surgery for suspected cancer, who are smokers with and without COPD compared to non-smokers patients


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥ 18
  • Patient undergoing lung resection surgery (lobectomy, pneumonectomy, segmentectomy) for cancer or suspected cancer
  • Acceptance to participate in the protocol
  • Affiliated to a social security plan

Exclusion Criteria8

  • Chronic autoimmune disease
  • Patient under guardianship or curators
  • Neo-adjuvant chemotherapy
  • History of thoracic radiotherapy
  • Pregnant woman
  • Minor patient
  • Person not able to consent
  • Person deprived of liberty

Interventions

OTHERThoracic resection surgery

Patients undergoing thoracic resection surgery (pneumonectomy, lobectomy, segmentectomy) for cancer or suspected cancer, including smokers (active or ex-smokers) and non-smokers, with COPD and without COPD, and non-smoking patients.


Locations(4)

Rousseau-Bussac

Créteil, France

Hopital Cochin

Paris, France

HEGP

Paris, France

Hopital Tenon

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05227547


Related Trials